In a 2024 article in Cell, the YTHDF2 protein is described as the key driver in aggressive blood cancers. The protein stabilizes RNA molecules to boost energy production, but it also helps these ...
The identification of the YTHDF2 protein is a significant breakthrough in cancer treatment. This CAR T cell therapy is effective against blood cancers like leukaemia and lymphoma, but many cancer ...